Try our Advanced Search for more refined results
May 16, 2018
GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc.
Case Number:
18-1976
Court:
Nature of Suit:
830 Patent Infringement (Fed. Qst.)
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 11, 2022
Sharply Split Full Fed. Circ. Won't Eye Skinny Label Ruling
Six Federal Circuit judges on Friday said they won't disturb a panel's finding that generic-drug maker Teva induced doctors to infringe a GlaxoSmithKline patent with its "skinny-label" version of the drug Coreg, much to the frustration of three colleagues.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login